SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, announced that ALYST Health has selected the SOBRsafe(TM) technology to use in its concierge addiction treatment services. ALYST offers the first and only at-home addiction-treatment program accredited by the Joint Commission, which is the oldest and largest health care standards-setting body in the country. According to the announcement, ALYST has purchased a supply of SOBRsure(TM) alcohol-detection wristbands with plans to use them as a more flexible, humane fully at-home alcohol treatment program. ALYST company officials noted that conventional treatment centers and conventional monitoring methods don’t always provide privacy or personalized treatment. With the addition of SOBRsure to its program, ALYST can move the point of care from the treatment center to the comfort and privacy of a client’s home without sacrificing quality and while offering dignity and remote monitoring, which the company believes will empower recovery success. “We are honored to work with ALYST, a standard-bearer for behavioral health innovation,” said SOBRsafe chair and CEO Dave Gandini in the press release. “We both seek to optimize recovery outcomes by looking beyond the walls of traditional treatment.”
To view the full press release, visit https://ibn.fm/SmPXv
About SOBR Safe Inc.
SOBRsafe offers an advanced transdermal (touch-based) technology that detects and instantaneously reports the presence of alcohol as emitted through a user’s skin — no breath, blood or urine sample is required. Alcohol misuse is the fourth leading cause of preventable death in America and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive, inefficient, unhygienic and unconnected. There has to be a better way. Enter SOBRsafe. With a powerful backend data platform, SOBRsafe provides next-generation, passive-detection technology for the behavioral health, judicial and consumer markets, as well as for licensing and integration. The SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure) and licensing/white labeling. SOBRsafe is creating a culture of prevention and support. For more information about SOBRsafe, visit www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at http://ibn.fm/SOBR
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN